To include your compound in the COVID-19 Resource Center, submit it here.

Viread tenofovir disoproxil fumarate: Phase II & III data; marketed

Combined analyses from Phase II and Phase III trials (studies 902 and 907) showed that patients receiving Viread plus their combination antiretroviral regimen

Read the full 232 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE